DNMT3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.830400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.542200E-01
Normal-vs-Stage2
4.956200E-01
Normal-vs-Stage3
3.467200E-01
Normal-vs-Stage4
4.274400E-01
Stage1-vs-Stage2
6.826800E-01
Stage1-vs-Stage3
6.408800E-01
Stage1-vs-Stage4
8.858000E-01
Stage2-vs-Stage3
5.160200E-01
Stage2-vs-Stage4
6.635000E-01
Stage3-vs-Stage4
7.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.312400E-01
Normal-vs-AfricanAmerican
3.609000E-01
Normal-vs-Asian
3.655000E-01
Caucasian-vs-AfricanAmerican
4.482600E-01
Caucasian-vs-Asian
5.169400E-01
AfricanAmerican-vs-Asian
7.939600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.923200E-01
Normal-vs-Female
6.673800E-01
Male-vs-Female
2.586000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.342800E-01
Normal-vs-Age(41-60Yrs)
6.984600E-01
Normal-vs-Age(61-80Yrs)
3.960400E-01
Normal-vs-Age(81-100Yrs)
4.173800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.796600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.809200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.308590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.559600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.324200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.035700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.063000E-01
Normal-vs-Daily Drinker
4.982000E-01
Normal-vs-Weekly Drinker
8.599400E-01
Normal-vs-Occasional Drinker
6.272600E-01
Normal-vs-Social Drinker
4.425800E-01
Non Drinker-vs-Daily Drinker
2.858000E-01
Non Drinker-vs-Weekly Drinker
3.017200E-01
Non Drinker-vs-Occasional Drinker
6.548200E-01
Non Drinker-vs-Social Drinker
9.329400E-01
Daily Drinker-vs-Weekly Drinker
1.754780E-01
Daily Drinker-vs-Occasional Drinker
1.912040E-01
Daily Drinker-vs-Social Drinker
4.075600E-01
Weekly Drinker-vs-Occasional Drinker
4.039600E-01
Weekly Drinker-vs-Social Drinker
2.981000E-01
Occasional Drinker-vs-Social Drinker
6.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.020600E-01
Normal-vs-Grade 2
5.905800E-01
Normal-vs-Grade 3
6.101000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.852200E-01
Grade 1-vs-Grade 3
6.713400E-01
Grade 1-vs-Grade 4
6.020600E-01
Grade 2-vs-Grade 3
1.111770E-01
Grade 2-vs-Grade 4
5.905800E-01
Grade 3-vs-Grade 4
6.101000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.062800E-01
Normal-vs-NonDiabetic
6.716000E-01
Diabetic-vs-NonDiabetic
6.359800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.897800E-01
Normal-vs-NoPancreatitis
5.222600E-01
Pancreatitis-vs-NoPancreatitis
5.296400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.970200E-01
Normal-vs-N1
5.636800E-01
N0-vs-N1
2.820000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.805200E-01
Normal-vs-TP53-NonMutant
3.066600E-01
TP53-Mutant-vs-TP53-NonMutant
7.499800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
